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Barbara E. Stranger,2,3,4,7,8,9,* and Philip L. De Jager1,2,3,4,8,*
Genome-wide association studies (GWASs) have identified hundreds of loci harboring genetic variation influencing inflammatory-
disease susceptibility in humans. It has been hypothesized that present day inflammatory diseases may have arisen, in part, due to
pleiotropic effects of host resistance to pathogens over the course of human history, with significant selective pressures acting to increase
host resistance to pathogens. The extent to which genetic factors underlying inflammatory-disease susceptibility has been influenced
by selective processes can now be quantified more comprehensively than previously possible. To understand the evolutionary forces
that have shaped inflammatory-disease susceptibility and to elucidate functional pathways affected by selection, we performed
a systems-based analysis to integrate (1) published GWASs for inflammatory diseases, (2) a genome-wide scan for signatures of positive
selection in a population of European ancestry, (3) functional genomics data comprised of protein-protein interaction networks, and (4)
a genome-wide expression quantitative trait locus (eQTL) mapping study in peripheral blood mononuclear cells (PBMCs). We demon-
strate that loci for inflammatory-disease susceptibility are enriched for genomic signatures of recent positive natural selection, with
selected loci forming a highly interconnected protein-protein interaction network. Further, we identify 21 loci for inflammatory-disease
susceptibility that display signatures of recent positive selection, of which 13 also show evidence of cis-regulatory effects on genes within
the associated locus. Thus, our integrated analyses highlight a set of susceptibility loci that might subserve a shared molecular function
and has experienced selective pressure over the course of human history; today, these loci play a key role in influencing susceptibility to
multiple different inflammatory diseases, in part through alterations of gene expression in immune cells.Introduction
The availability of genome-wide genetic variation data
from population-based cohorts, coupled with improved
analytic methods, have led to a number of genome-wide
scans for selection that have collectively identified
hundreds of regions targeted by recent positive selection,
many of which harbor genetic variants implicated in
inflammatory diseases.1–15 Interestingly, for many of these
variants, selection has favored the haplotypes carrying
disease risk alleles, suggesting a potential beneficial role
for the risk allele in the course of human history, presum-
ably for another function (e.g., resistance to pathogens).1
For example, individuals homozygous for the Crohn
disease (MIM 266600) risk allele at rs601338 in FUT2
(MIM 182100) are protected from norovirus infec-
tion.16,17 Similarly, it was shown that the positively
selected celiac disease (MIM 212750) risk variant in
SH2B3 (MIM 605093) might have a protective role against
bacterial infections.18 Further, the major histocom-
patibility complex (MHC) contains several alleles that
are strongly associated with susceptibility to different
inflammatory diseases and have experienced strong
selection that has been attributed to host-pathogen
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The Amthe ‘‘hygiene hypothesis,’’ which posits that protective
immune responses in a setting with high exposure to
pathogens (which was the norm for most of human
history) have become deleterious and contribute to
inflammatory-disease susceptibility in the modern era
of enhanced hygiene and extended lifetimes. With
a genetic lens, the hypothesis states that risk alleles for
inflammatory disease have been maintained in the
human population as a result of adaptation to pathogen
exposures that were endemic in the past but are no longer
a significant burden in developed societies today.22,23
Although the studies listed above provide anecdotal
evidence for a role for pathogen-driven selection at several
inflammatory-disease loci, a systematic analysis exploring
the role of natural selection in influencing susceptibility
to inflammatory disease has not been performed. Until
recently, the genetic architecture of inflammatory diseases
was relatively uncharacterized, precluding a comprehen-
sive analysis. Even with the recent catalogs of robust,
replicated inflammatory-disease associations, several chal-
lenges to our understanding of disease-associated variation
remain, including identifying the causal variant(s) within
each locus and understanding how the dozens of known
variants assemble into networks that ultimately lead to
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modern environment. Here, we perform a systematic
analysis for evidence of natural selection to inform these
two challenges, and we integrate our results with analyses
of protein interaction networks and gene expression
data (expression quantitative locus [eQTL] mapping) in
immune cells. The results of these analyses support the
hypothesis that a specific network of immune genes has
undergone natural selection in populations of European
origin—the population in which virtually all of the sus-
ceptibility alleles have been discovered—and plays an
important role in susceptibility to inflammatory diseases
in our current environment. These analyses may con-
tribute to the identification of causal variants and the
elucidation of functional mechanisms underlying disease
susceptibility; they may also aid in the interpretation of
likely agents and targets of positive selection through
elucidation of functional effects on specific biological
pathways or functional modules.24
Specifically, we performed a genome-wide scan for
recent positive selection by using long-range haplotype
tests and we identified 21 (out of 416) inflammatory-
disease variants exhibiting significant signatures of
selection in a population of European ancestry. We note
that the genes found in these selected loci can be assem-
bled, independently, into a molecular pathway via
a protein-protein interaction (PPI) network approach. To
identify potential mechanisms for disease susceptibility
and potential gene targets of selection, we also performed
an eQTL analysis in peripheral blood mononuclear
cells (PBMCs) of 228 individuals with an inflammatory
demyelinating disease of the central nervous system. Of
the 21 susceptibility loci with signatures of selection, we
identified 13 variants that exhibit cis-regulatory effects in
PBMCs, a mixture of cell types with important roles in
both adaptive and innate immunity. Further, previously
published data on transcriptional response to pathogens
provide functional evidence that the affected genes
play a significant role in orchestrating pathogen-specific
immune response.25,26 Thus, our results suggest that
a subset of genes for inflammatory-disease susceptibility
can be assembled into a molecular pathway whose com-
ponent molecules (1) have experienced a shared evolu-
tionary history in response to selective pressures that
may have been acting on host resistance to pathogens
and (2) serve a shared molecular function in the immune
system that is dysregulated in several inflammatory
diseases.Material and Methods
Genome-wide Association Studies Data
We obtained data from published GWASs via the National Human
Genome Research Institute (NHGRI) GWAS catalog available
online (December 20, 2011, version). To compile the most recent
and comprehensive list, we also mined literature for inflammatory
SNPs from GWASs. We used SNPs reported to be associated to
complex traits with a p value of at least 5 3 108. A list of the518 The American Journal of Human Genetics 92, 517–529, April 4, 2complex traits from the GWAS catalog included for each of the
five major trait groups is in Table S3 available online.
To test for enrichment for selection, we selected ten inflamma-
tory diseases: ankylosing spondylitis (AS [MIM 106300]), Crohn
disease (CD), celiac disease (CeD), multiple sclerosis (MS [MIM
126200]), primary biliary cirrhosis (PBC [MIM 109720]), psoriasis
(PS [MIM 177900]), rheumatoid arthritis (RA [MIM 180300]),
systemic lupus erythematosus (SLE [MIM152700]), type 1 diabetes
(T1D [MIM 222100]), and ulcerative colitis (UC [MIM 191390])
(Table S1). These inflammatory diseases were selected because
they had the largest repertoire of common, non-MHC variants
(validated and replicated variants) at the beginning of this study.
In addition, these ten inflammatory diseases were the focus of
the ImmunoChip Consortium,27 which designed a custom-made
SNP chip relevant to multiple immune-mediated diseases.
The Integrated Haplotype Score
The integrated haplotype score (iHS) statistic was computed as
described in Voight et al.2. We used the iHS software to compute
genome-wide iHSs on SNPs with minor allele frequency (MAF)
>0.05 using the Phased haplotype data from three HapMap II
populations: African (Yoruba from Ibadan, Nigeria; YRI), CEU
(Utah residents with ancestry from northern and western Europe
from the CEPH collection; CEU), and East Asian (Japanese subjects
from Tokyo and Han Chinese subjects from Beijing representing
Asian populations; ASI). The iHSs can also be retrieved from the
Haplotter website.
The CEU HapMap II Phased haplotypes for each chromosome
were downloaded from the HapMap FTP site. The ancestral states
for HapMap phase II data were based on alignment to the
chimpanzee sequence and were downloaded from the Haplotter
website. The population-specific recombination map positions
were downloaded from the HapMap FTP site. We standardized
the iHS values by normalizing the given unstandardized iHS
by the mean and standard deviation of other iHSs observed across
the genome, with similar derived allele frequencies.
Calculating the FST Statistic
We calculated unbiased estimates of FST as described by Weir and
Cockerham.28 We calculated the global FST for each single SNP
among the three HapMap populations. For autosomal HapMap
II SNPs, we considered a candidate selection if the SNP FST R
0.58, which corresponds to a genome-wide empirical significance
level of a ¼ 0.01.
Estimating the Age of Selective Sweep
To obtain a rough estimate of the age of the selective sweep, we
first computed the extended haplotype homozygosity (EHH)3 by
a web-based tool (Web-EHH) for the chromosomal segments
with evidence for selection.29 Using the EHH scores, we computed
the recombination distance r by using the distance (in cM)
between the points where EHH ¼ x to the left and to the right of
the core SNP. We can obtain r from any given x (i.e., EHH ¼
0.25). The generation time G can be calculated as G ¼ (ln x / –r)
3 100.18 Assuming a mean generation time of 25 years, the age
of the selective sweep for the derived allele is 25 3 G.
Protein-Protein Interaction Network
A protein-protein interaction (PPI) network was reconstructed
with the online tool DAPPLE with 1,000 permutations and 2
interacting binding degree as a cutoff.30 The 37 inflammatory013
disease SNPs consistent with patterns of recent positive selection
(jiHSj > 1.65; p < 0.1) were included as an input to DAPPLE.
DAPPLE then converts into genes based on overlapping wingspan,
a region containing SNPs with r2 > 0.5; this region is then
extended to the nearest recombination hotspot. DAPPLE recon-
structs networks of PPI representing proteins as nodes connected
by an edge if there is in vitro evidence of interaction based on
the InWeb database, which contains 169,810 high-confidence
pair-wise interactions involving 12,793 proteins.31 DAPPLE recon-
structs two types of networks: (1) direct network, two associated
proteins can be connected by exactly one edge, and (2) indirect
network, where associated proteins can be connected via common
interactor proteins with which the associated proteins each share
an edge. To assess the statistical significance of the PPI networks,
DAPPLE constructs random networks (mimicking the structure
of the original network) from a within-degree node-label permuta-
tion strategy (see Rossin et al.32 for further details). An empirical
distribution is constructed for each network connectivity param-
eter and used to evaluate the statistical significance of networks.Expression QTL Analysis
Gene expression levels were quantified with mRNA derived from
peripheral blood mononuclear cells (PBMCs) of 228 subjects of
European ancestry with relapsing remitting (RR) multiple sclerosis
(MS) via an Affymetrix Human Genome U133 Plus 2.0 Array.
These data were collected between July 2002 and October 2007
as part of the Comprehensive Longitudinal Investigation of MS
at the Brigham and Women’s Hospital. The expression levels
were adjusted for confounding factors, such as subject’s use of
immunomodulatory drugs, age, gender, and batch effects via prin-
ciple components analysis.33
DNA from each individual was genotyped on the Affymetrix
550K GeneChip 6.0 platform as a part of a previously published
study.33 The genotyped data sets were imputed with the CEU
samples in HapMap Phase II (~2.5 million SNPs) as the reference.
Associations between SNP genotypes and adjusted expression
values were conducted by Spearman rank correlation (SRC). For
the cis analysis, we considered only SNPs within a 1 MB window
from the transcript start site (TSS) of genes. Significance of the
nominal p values was determined by comparing the distribution
of the most significant p values generated by permuting expres-
sion phenotypes 10,000 times independently for each gene.34
We call a cis-eQTL significant if the nominal association p value
is greater than the 0.05 tail of the minimal p value distribution re-
sulting from the permuted associations.
Similar methods were used to evaluate the cis-regulatory effects
in CD4þ T lymphocytes and CD14þCD16 monocytes data sets
consisting of 80 healthy individuals of European ancestry. These
analyses were conducted under the auspices of a protocol
approved by the institutional review board of Partners Healthcare.Results
Loci for Inflammatory-Disease Susceptibility Are
Enriched for Signatures of Recent Positive Selection
To test whether inflammatory-disease susceptibility loci are
enriched for signals of positive selection, we first compiled
a list of single-nucleotide polymorphisms (SNPs) associated
with complex traits from the December 10, 2011, version
of the National Human Genome Research InstituteThe Am(NHGRI) GWAS catalog, which includes 1,107 published
association studies of 5,481 SNPs (p value < 106) to
more than 550 traits, of which 588 SNPs are associated
with ten inflammatory diseases, i.e., ankylosing spondylitis
(AS), Crohn disease (CD), ulcerative colitis (UC), celiac
disease (CeD), multiple sclerosis (MS), type 1 diabetes
(T1D), rheumatoid arthritis (RA), primary biliary cirrhosis
(PBC), systemic lupus erythematosus (SLE), and psoriasis
(PS) (Table S1). To identify a nonredundant set of associated
variants, we LD pruned (keeping the most strongly associ-
ated SNP and removing those with an r2 > 0.4) the 588
SNPs, which resulted in 416 independent associations,
and this set was used for all the subsequent analysis. All
of the discovery studies used subjects of European ancestry.
To quantify signatures of positive selection in the human
genome, we searched for regions of the genome where the
pattern of genetic variation is consistentwith that expected
under a model of recent positive selection. For our analysis
we use the integrated haplotype score (iHS) as our primary
measure of selection. The iHS statistic was primarily
developed to detect positive selection and is sensitive
to detecting soft sweeps or incomplete sweeps. Many of
the GWAS SNPs are probably evolving under such
sweeps.10,35 The iHS statistic uses the lengths of the haplo-
types surrounding each core SNP to identify SNPs for
which alleles have rapidly risen in frequency.2,3We applied
iHS to genome-wide HapMap Phase II SNPs (MAF > 0.05)
in the CEU population (Utah residents with ancestry
from northern and western Europe from the CEPH collec-
tion). As a secondary analysis, we also examined differences
in allele frequencies (global FST) between the three HapMap
populations (subjects of East Asian [Han Chinese from
Beijing and Japanese from Tokyo], European [CEU], and
African [Yoruba from Ibadan, Nigeria] ancestry) at disease-
associated SNPs. Because FST provides a metric of the
magnitude of global allele frequency differentiation, it is
less sensitive todetecting population-specific positive selec-
tion signals than iHS,36 and it is these population-specific
signals that aremost pertinent in our evaluation of variants
associated with disease in European populations.
In our primary analysis, we therefore searched for
inflammatory-disease SNPs that localize to regions of the
genome where patterns of genetic variation are consistent
with evidence for recent positive selection. Of 416
SNPs associated with inflammatory diseases that are
considered in our analyses, 21 SNPs exhibited a signifi-
cant signal of selection at p < 0.05 (jiHSj > 2) after correct-
ing for genome-wide testing, with 13 loci meeting or
exceeding the more rigorous corrected threshold of p <
0.01 (jiHSj > 2.6) (Table 1). To assess how extreme these
results are, we also performed simulations to test for an
enrichment of positive selection among SNPs associated
with inflammatory disease relative to other SNP sets: we
generated 10,000 SNP sets sampled at random from bins
matched for minor allele frequency (MAF), haplotype
block length, and genic/nongenic status to the 416 sus-
ceptibility variants. With this distribution, the 13erican Journal of Human Genetics 92, 517–529, April 4, 2013 519
Table 1. Inflammatory Disease-Associated Variants that Localize to Regions with Evidence of Positive Selection
Chr SNP Diseasea
Derived/Ancestral
Allele Risk Alleleb
Derived
Allele Freq. FST iHS Genes within 50 kb
7q11 rs1167796 SLE G/A G 0.53 0.24 5.64 HIP1 (MIM 601767)
6p21 rs3131379 SLE A/G A* 0.10 0.06 3.18 VARS (MIM 192150),
LSM2 (MIM 607282)
12q24 rs17696736 T1D G/A G* 0.35 0.35 3.10 TMEM116
19q13 rs281379 CD G/A A* 0.42 0.45 2.98 FUT2 (MIM 182100),
FUT1 (MIM 211100)
12q24 rs3184504 RA, T1D T/C T* 0.41 0.40 2.97 SH2B3 (MIM 605093),
ATXN2 (MIM 601517)
6q21 rs11962089 MS G/A G 0.16 0.47 2.81 POPDC3 (MIM 605824)
4q27 rs6822844 CeD, RA, UC T/G G 0.21 0.20 2.82 IL2 (MIM 147680),
IL21 (MIM 605384)
3q13 rs4308217 MS A/C C 0.43 0.45 2.73 CD86 (MIM 601020)
3q25 rs12638253 MS T/C NR 0.48 0.20 2.71 LEKR1 (MIM 613536)
3q25 rs17810546 CeD G/A G* 0.10 0.09 2.66 SCHIP1 (MIM 611622),
IL12A (MIM 161560)
3q13 rs1132200 MS T/C NR 0.12 0.06 2.68 ARHGAP31
(MIM 610911),
STAT1 (MIM 600555)
19q13 rs307896 MS T/C C 0.23 0.41 2.62 SAE1 (MIM 613294)
5q31 rs2188962 CD T/C T* 0.45 0.43 2.60 SLC22A5 (MIM 603377),
IRF1 (MIM 147575)
16p13 rs12708716 MS, T1D G/A A* 0.28 0.03 2.32 CLEC16A (MIM 611303)
6p21 rs11755393 SLE A/G NR 0.63 0.12 2.28 UHRF1BP1 (MIM 612253)
2q37 rs10210302 CD C/T T* 0.45 0.14 2.18 INPP5D (MIM 601582),
ATG16L1 (MIM 610767)
6q27 rs415890 CD G/C NR 0.48 0.12 2.15 RNASET2 (MIM 612944)
6p21 rs3129934 MS T/C T* 0.25 0.09 2.12 BTNL2 (MIM 606000)
5p13 rs10440635 AS G/A A* 0.36 0.43 2.03 PTGER4 (MIM 601586)
19q13 rs3745516 PBC A/G A 0.20 0.49 2.01 SPIB (MIM 606802)
21q22 rs2838519 UC A/G G* 0.49 0.25 2.00 ICOSLG (MIM 605717)
20q13 rs2248359 MS C/T C* 0.63 0.24 1.93 CYP24A1 (MIM 126065)
16p13 rs6498169 MS A/G G* 0.61 0.06 1.90 CLEC16A (MIM 611303)
11q23 rs678170 UC A/G NR 0.69 0.20 1.90 FAM55A, FAM55D
16q12 rs5743289 CD C/T T* 0.73 0.26 1.90 SNX20 (MIM 613281),
NOD2 (MIM 605956)
2q12 rs2058660 CD G/A G* 0.23 0.08 1.88 IL18RAP (MIM 604509)
10p15 rs12722489 CD, MS T/C C 0.16 0.07 1.88 IL2RA (MIM 147730)
10q24 rs10786436 T1D T/C T 0.34 0.08 1.82 HPSE2 (MIM 613469)
2p14 rs17035378 CeD T/C NR 0.70 0.16 1.82 PLEK (MIM 173570)
15q23 rs17374222 RA A/C A* 0.49 0.08 1.81 KIF3 (MIM 604683)
6p21 rs2647044 T1D G/A A* 0.91 0.02 1.78 HLA-DQB1 (MIM
604305), HLA-DQA2
(MIM 613503)
6q23 rs11154801 MS A/C A 0.32 0.15 1.77 AHI1 (MIM 608894)
6p22 rs2285797 MS G/A NR 0.32 0.06 1.77 TRIM10 (MIM 605701)
2q32 rs10931468 PBC C/A A* 0.82 0.10 1.74 STAT4 (MIM 600558)
(Continued on next page)
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Table 1. Continued
Chr SNP Diseasea
Derived/Ancestral
Allele Risk Alleleb
Derived
Allele Freq. FST iHS Genes within 50 kb
4q21 rs4333130 AS C/T NR 0.45 0.66 1.74 ANTXR2 (MIM 608041)
17q21 rs744166 CD, MS A/G A* 0.56 0.10 1.72 STAT3 (MIM 102582)
5p13 rs6897932 MS, T1D C/T C* 0.24 0.11 1.66 IL7R (MIM 146661)
Abbreviations are as follows: iHS, integrated haplotype score; NR, not reported; Freq., frequency.
aAbbreviations are as follows: AS, ankylosing spondylitis (MIM 106300); CD, Crohn disease (MIM 266600); CeD, celiac disease (MIM 212750); MS, multiple scle-
rosis (MIM 126200); PBC, primary biliary cirrhosis (MIM 109720); PS, psoriasis (MIM 177900); RA, rheumatoid arthritis (MIM 180300); SLE, systemic lupus eryth-
ematosus (MIM 152700); T1D, type 1 diabetes (MIM 222100); UC, ulcerative colitis (MIM 191390).
bAn asterisk (*) indicates that the risk allele lies on the positively selected haplotype.haplotypes with putative positively selected SNPs meeting
an jiHSj> 2.6 threshold are unlikely to have been observed
by chance alone (p < 0.0001; Figure 1, left). This result
suggests that loci for inflammatory-disease susceptibility
are more likely to be located on positively selected haplo-
types than matched SNP sets.
We have also performed an analysis to assess whether
the loci harboring risk variants associated with common
inflammatory diseases are significantly enriched for signals
of selection relative to immune response genes that are not
known to be associated with susceptibility to inflamma-
tory disease. In this analysis, we find that, at an jiHSj >
2.6, there are 3% (13/413 SNPs) of susceptibility variants
under positive selection compared to 0.6% (23/3,654
SNPs) of LD-pruned variants found in the vicinity of genes
previously defined as being involved in immune func-
tion37 (p < 0.0001) (see Supplemental Data for details of
the analysis; Figure S1). This result suggests that risk vari-
ants for inflammatory diseases are significantly enriched
for signatures of selection relative to variants in immune
genes that influence immune function but are not associ-
ated with disease (Figures S1 and S2).
Interestingly, we find that 21 of the 30 reported risk
alleles (out of 37; Table 1) with evidence of selection lie
on the positively selected haplotypes, suggesting that the
disease-associated risk alleles are, on average, more likely
to be targets of selection than the protective allele (bino-
mial test p ¼ 0.043). However, we note that these analyses
are complicated by the fact that some variants are associ-
ated withmore than one inflammatory disease, and indeed
there are examples where a given allele is protective against
one disease and a risk allele for another.38,39
In a secondary analysis, we deployed the FST metric,
a different method for assessing evidence of natural selec-
tion, and compared the number of SNPs associated with
inflammatory diseases in the 1% tail of global FST to a distri-
bution comprised of MAF- and genic/nongenic status-
matched SNPs sampled at random 10,000 times from the
empirical distribution; here, we find that inflammatory
disease SNPs are more highly differentiated across human
populations than expected by chance (observed nine
SNPs meeting this threshold; p ¼ 0.006; Figure 1, right).
Of the 13 putative positively selected SNPs in the jiHSj anal-
ysis, 10 also have high global FST score (above genome-wideThe Amaverage; FST > 0.11), suggesting that these variants might
represent the true variants that are under selection.
To determine whether SNPs associated with inflamma-
tory diseases show greater enrichment for signatures of
selection relative to those associated with other disease
classes, we compared the overall distribution of iHS across
different classes of complex traits. By using the 5,481
SNPs from the GWAS catalog, we selected SNPs associated
with one of five trait classes (inflammatory disease, cancer,
neurological/psychiatric disease, metabolic disease, and
height), and we LD pruned variants within each group
by removing SNPswith an r2> 0.4 with a SNPwith a higher
reported p value for a given trait (Table S2).
Although we do not observe a major shift in the entire
distribution of iHSs between inflammatory disease SNPs
and those of the other trait classes, we note that variants
associated with inflammatory diseases may be somewhat
enriched in the 1% tail of the empirical distribution for
iHS (data not shown). So, we tested for enrichment among
inflammatory-disease SNPs at the top 5% and 1% of iHS
(Figure 2). Among the top 1% of iHS signals (jiHSj >
2.6), we observe that inflammatory diseases have a higher
proportion of SNPs (3.1%) targeted by positive selection
than the other trait groups (Figure 2). This enrichment is
significant when compared to the distribution observed
in all SNPs genotyped in CEU subjects of the HapMap
Phase II resource (Pearson’s c2 test, p ¼ 1.1 3 105).
Thus, overall, it appears that the class of inflammatory-
disease variants has experienced more selection in
subjects of European ancestry than is expected by chance
alone.
Positively Selected Genes Encode Proteins that
Directly Interact in PPI Network
Having observed robust evidence of natural selection in
a subset of loci for inflammatory-disease susceptibility,
we next investigated whether the selected loci might serve
a shared cellular function that could have been the target
of selective pressure over the course of human history.
We used an approach that leverages protein-protein
interaction maps to see whether the selected loci could
be assembled into a single network of genes that have
a correlated evolutionary history.32,40,41 We tested this
hypothesis by using a robust method for the assessmenterican Journal of Human Genetics 92, 517–529, April 4, 2013 521
Figure 1. Inflammatory-Disease SNPs
Are More Likely to Have Experienced
Recent Positive Selection
The distribution of the number of SNPs
with jiHSj > 2.6 (left) and highly differen-
tiated SNPs (top 1% of the empirical
genome-wide FST distribution) (right)
observed for each of 10,000 draws of 416
SNPs matched for MAF, haplotype length,
and genic/nongeneic status to the 416
inflammatory disease SNPs (see Table S1
for a list of diseases). Shown in solid blue
circle are the observed number of SNPs
with jiHSj > 2.6 (13 SNPs; p < 0.0001)
and high FST (8 SNPs; p ¼ 0.006). A dotted
red line further highlights this result.of functional connectivity, the disease association protein-
protein link evaluator (DAPPLE) algorithm, that requires
evidence of functional connectivity as well as
coexpression in at least one tissue.32 DAPPLE defines
a genomic region around each SNP in terms of LD and
considers any protein encoded within that region. We
pursued the DAPPLE analyses with a slightly more relaxed
threshold (jiHSj > 1.6) to enhance the dissection of the
pathways. Using more relaxed threshold in the network
analyses is one approach to identify which of the loci
with suggestive evidence of selection share certain func-
tional information with the significant loci.
We found that 15 of 37 putative positively selected loci
(p < 0.1; jiHSj > 1.6) are directly connected and 28 loci
are indirectly connected (via an interactor protein that
is not known to be under selection). These results suggest
the existence of functional connections between proteins
encoded in the selected regions. When compared to
10,000 random networks, we found that the direct
network connectivity was statistically significant beyond
that expected by chance (permuted p ¼ 9.91 3 105,
Figure 3). The model for indirect connectivity via common
interactors that are not among the most selected loci was
also significant (permuted p ¼ 0.0027; Figure S3).
Our observation that there are significant numbers of
direct connections between proteins in inflammatory-
disease loci under selection is not surprising, as it has
been previously shown that genes in loci associated with
inflammatory diseases (i.e., RA and CD) are significantly
connected via protein-protein interactions.32 Whereas
these studies have identified elements of the network
that we present (Figure 3), we explored the possibility
that the proteins encoded in loci for inflammatory-disease
susceptibility that have evidence for selection are more
densely connected than those located near random sets
of loci for inflammatory-disease susceptibility. Connec-522 The American Journal of Human Genetics 92, 517–529, April 4, 2013tivity within the latter, randomly
selected pools of disease-associated
SNPs may simply reflect the more
general connectivity of immune
pathways.32 To statistically evaluate
the connectivity of the positivelyselected PPI network, we therefore generated 1,000
random sets of 37 SNPs (tomatch the number of putatively
selected loci) from the 416 SNPs associated with inflamma-
tory diseases and constructed PPI networks from each set.
With these results, we observe that the mean direct
connectivity for the PPI generated from selected variants
(Figure 3) falls in the top 1% of the empirical distribution
for random inflammatory-disease susceptibility networks
and is unlikely to have occurred by chance alone (p <
0.014; Figure S4). This result suggests that proteins en-
coded in the positively selected inflammatory-disease loci
are more highly interconnected than those encoded by
loci for inflammatory-disease susceptibility in general.
Given their similar evolutionary history and the indepen-
dent evidence of functional connectivity between them,
this group of selected susceptibility genes is more likely
to serve a shared molecular function that was advanta-
geous in response to a selective pressure encountered by
European populations over the course of their history.
To investigate whether the genes of the core selected
pathway have been targets of selection in response to
a shared selective pressure, we estimated the age of the
haplotypes carrying the selected risk alleles to see whether
their ages converge. To estimate the age of a putative selec-
tive event, we first calculated the extended haplotype
homozygosity (EHH) for each haplotype, assuming a star
phylogeny of the haplotypes and an average generation
time of 25 years (see Material and Methods). In the Euro-
pean populations where the susceptibility alleles have
been discovered, the estimated age of a putative selective
sweep for the components in the core, directly connected
network (Figure 3) is in the range of 1,200–2,600 years ago
(estimates of the age of the selective sweep for the derived
allele are listed in Table S4). These estimates are coarse
approximations, and this method is particularly well pow-
ered for recent selective events. Appreciating these
Figure 2. Proportion of Trait-Associated
SNPs that Localize to Regions with
Evidence of Recent Positive Selection
Shown here are GWAS SNPs from five
major trait groups: all GWAS SNPs (LD
pruned; n ¼ 4,056), cancers (n ¼ 209),
height (n ¼ 188), inflammatory diseases
(n ¼ 416), metabolic diseases (n ¼ 326),
and neurological/psychiatric diseases
(n ¼ 68). The trait-associated SNPs are LD
pruned to r2 < 0.4; shown here are SNPs
with jiHSj > 2 in blue bars and jiHSj >
2.6 in red bars. The proportion of SNPs
at different iHS thresholds are shown in
white inside each bar. Inflammatory
diseases have a higher proportion of SNPs
(3.1% at iHS > j2.6j) targeted by positive
selection than other trait groups (Pearson’s
c2 test, p ¼ 1.1 3 105). We highlight this
category with an asterisk.limitations, it nonetheless appears that the selective forces
influencing allele frequencies in the core selected network
that we have identified occurred over the course of recent,
recorded human history.
Positively Selected Inflammatory Risk Variants Have
cis-Regulatory Effects in Activated Immune Cells
To examine the mechanism(s) by which the selected
variants may influence immune function, we assessed
each of the 21 inflammatory disease loci with jiHSj > 2
for evidence of an effect on RNA expression levels in cis.
That is, we performed an expression quantitative trait
locus (eQTL) analysis in each locus for genes in the vicinity
of the disease-associated SNP. We first investigated genetic
variation and mRNA expression levels in a data set derived
from peripheral blood mononuclear cells (PBMCs) of 228
individuals of European ancestry with an inflammatory
demyelinating disease of the central nervous system (a
clinically isolated demyelinating syndrome or multiple
sclerosis), representing a set of subjects with an activated
immune system. To investigate our findings in other
immune-relevant cell types, we also performed eQTL anal-
yses in independent data sets generated from flow-sorted
CD4þ T lymphocytes and CD14þCD16 monocytes
(both of which are constituents of the PBMC mixture) of
80 healthy subjects from the Immunological Variation
(ImmVar) project and also evaluated previously published
eQTL data sets including HapMap LCLs,42 CD4þ T
lymphocytes from asthmatics,43 and monocytes from
healthy individuals.30 These genome-wide eQTL data
from multiple immune cell types enhance our ability to
identify functional effects of genetic variation on gene
expression levels and allow us to assemble a frameworkThe American Journal of Humanfor understanding which cells and
cell functions are affected by each
variant.
Of the 21 inflammatory-disease
variants exhibiting signatures of
selection, 13 variants had cis-regula-tory effects on gene expression levels in the available
data (Table 2). Among the inflammatory diseases, MS-,
CD-, and T1D-associated risk variants were the most abun-
dant among those exhibiting selection and eQTL effects,
most probably due to large number of variants discovered
for these diseases (Table 2). One locus with overlapping
signals (selection, eQTL, and disease association) contains
the SLE risk allele rs11755393G, which is under selection
(iHS ¼ 2.28) and is strongly associated with PBMC RNA
expression of the ICBP90 binding protein 1 (UHRF1BP1
[MIM 612253]; p ¼ 7.53 3 1042), a putative binding
partner of UHRF1, a RING-finger type E3 ubiquitin
ligase44 (Figure 4). For this locus, we further replicated
the cis-regulatory effect in data generated from CD4þ T
lymphocytes (p ¼ 5.65 3 1010; Figure S5) and CD14þ
CD16 monocytes (p ¼ 3.57 3 1010; Figure S6) of 80
healthy individuals of European ancestry: in all three
data sets, the SLE susceptibility allele rs11755393G is asso-
ciated with decreased UHRF1BP1 RNA expression. In
PBMCs, the regulatory trait concordance scores (RTCs),46
an index integrating eQTL and GWAS data to detect
disease-causing regulatory effects, were equal to one (RTC
¼ 1), suggesting that the genetic variant underlying disease
susceptibility and cis-regulatory signals are the same. Other
genes with cis-eQTLs and signals of selection are listed in
Table 2.Discussion
The results presented here provide support for recent
positive selection having shaped a portion of genetic vari-
ation influencing inflammatory-disease susceptibility toGenetics 92, 517–529, April 4, 2013 523
Figure 3. Directly Connected Protein-Protein Interaction Network
The protein-protein interaction (PPI) network was generated from genes found in inflammatory disease haplotypes with evidence for
positive selection. Human RefSeq Genes are represented as nodes (colored by locus); edges indicate known direct functional connection
according to the PPI algorithm.32 The network is statistically significant for direct connectivity more than would be expected by chance
(mean direct connectivity, 3.13; expected, 1.18; permuted p ¼ 9.91 3 105).a greater extent than genetic variation associated with
other common diseases. We show that several genes found
in these disease-associated, positively selected haplotypes
can be assembled, independently, into a molecular
complex via a protein-protein interaction (PPI) network
approach. This network of selected genes is significantly
more connected than random networks of genes for
inflammatory-disease susceptibility, suggesting that these
selected genes may have served a shared molecular mech-
anism that experienced selective pressure over human
history. More specifically, the core of the directly con-
nected, selected protein network (Figure 3) captures molec-
ular pathways involved in lymphocyte activation.
Although many of these genes are expressed in different
subsets of immune cells and our understanding of the
role of specific genes across immune cell types is incom-
plete, a subset of T cells stands out as being influenced by524 The American Journal of Human Genetics 92, 517–529, April 4, 2a majority of the genes in the directly interconnected
network: pathogenic Th17 and Th1 cells that play an
important role in several inflammatory diseases such as
Crohn disease, multiple sclerosis, rheumatoid arthritis,
and type 1 diabetes mellitus.47–50
A careful balance exists among Th17, Th1, Th2, regula-
tory T (Treg) cells, and other immune cells to maintain
the homeostasis of the immune system. In inflammatory
diseases, this balance is disrupted, with the frequency
and function of these cell types being altered. In the core
network of 17 directly connected genes (Figure 3), derived
from inflammatory disease susceptibility genes with
evidence of selection, we find genes that (1) induce Th17
cell differentiation (IL21 [MIM 605384], STAT3 [MIM
102582]), (2) prevent Th17 cell differentiation (IL12A
[MIM 161560]), (3) regulate Th17 cell function (IRF1
[MIM 147575], STAT1 [MIM 600555]), (4) are involved013
Table 2. Inflammatory Disease-Associated Variants that Localize to Regions with Evidence for cis-Regulatory Function and Positive Selection
Locus
7q11 6p21 12q24 19q13 12q24 3q13 19q13 3q13 5q31 16p13 6p21 2q37 6q27
SNP rs1167796 rs3131379 rs17696736 rs281379 rs3184504 rs4308217 rs307896 rs1132200 rs2188962 rs12708716 rs11755393 rs10210302 rs415890
Disease SLE SLE T1D CD RA, T1D MS MS MS CD MS, T1D SLE CD CD
Minor (risk) allele A(G) A(A) G(G) A(A) T(T) A(C) A(G) A(NR) T(T) G(G) G(NR) T(T) C(C)
MAF 0.29 0.05 0.2 0.27 0.21 0.19 0.13 0.12 0.17 0.34 0.45 0.39 0.4
iHS 5.64 3.18 3.1 2.98 2.97 2.73 2.62 2.54 2.34 2.32 2.28 2.18 2.15
cis-regulated gene PMS2L3 VARS2 C12orf47 LILRB5 TMEM116 CD86 SAE1 POGLUT1 IRF1 DEXI UHRF1BP1 ATG16L1 RNASET2
eQTL Cell Typesa
This Study
PBMC (n ¼ 228) þ – þ – þ – – – þ þ þ – þ
RTC (PBMC) 0.91 0.78 0.62 NA 0.76 NA NA NA 0.85 0.73 1 NA 0.94
CD14þCD16 Monocytes (n ¼ 80) – – – þ – – – – þ – þ – þ
CD4þ T Cells (Healthy) (n ¼ 80) – – – – – – – – – – þ – þ
Published
Blood Monocytes (n ¼ 1,490)30 þ þ þ þ – – – – – þ þ – þ
CD4þ T Cells (Asthmatics) (n ¼ 200)43 – – – – – – þ þ þ – – þ þ
LCLs (CEU HapMap) (n ¼ 109)42 – – – – – – – – – – – þ –
LCLs (Asthmatics) (n ¼ 400)60 – – – – – þ – þ – – – þ –
Abbreviations are as follows: iHS, integrated haplotype score; MAF, minor allele frequency; RTC, relative trait concordance, a score integrating eQTL and GWAS data to detect disease-causing cis-regulatory effects. RTC scores
are calculated only in PBMC.
aSignificant cis-eQTLs are indicated by ‘‘þ.’’ The PBMC is our primary data set and for replication we used gene expression data from CD14þCD16 monocytes and CD4þ T cells of 80 healthy subjects (data not shown).
The other cis-eQTL results presented here were reported as significant in the published studies that we reference.
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Figure 4. Colocalization of cis-Regula-
tory Effects and Positive Selection Signal
in the UHRF1BP1 Locus
The top panel reports the cis-regulatory
effects of each SNP on UHRF1BP1 RNA
expression in PBMC; -log10 (p value) is
reported on the y axis. The lower panel
reports the scores for evidence of positive
selection (iHS) for each SNP over the
same chromosomal segment. The RefSeq
genes in the region are shown at the
bottom of the figure. The LD (in r2) for
each SNP with the index SLE-associated
UHRF1BP1 SNP (rs11755393; shown in
purple) is illustrated with the use of
colors, as indicated in the top right of
the figure. This figure was generated by
LocusZoom.45in Th17 cell function (CSF2 [MIM 138960], IL3 [MIM
147740], STAT3 [MIM 102582]), and (5) induce and main-
tain Treg cells that inhibit Th17 and other pathogenic cells
(IL2 [MIM 147730], IL2RA [MIM 147730], SOCS1 [MIM
603597], STAT5 [MIM 601511]).51 Several of these genes
also influence the function of other immune cell subsets,
but the overlay of our core selected network with
molecular pathways that are important for Th17 and
Treg cell function is consistent with an extensive, recent
immunologic literature that has defined a prominent
role of these cell types in inflammatory diseases.47,52
At this time, it is not clear what selective pressure may
have led to the signals of natural selection that we
have uncovered in populations of European ancestry:
favorable responses to one or more pathogen during the
history of European populations is a reasonable scenario,
particularly since the Th17 cell pathway that emerges
from our analysis has evolved to confer protective immu-
nity against extracellular bacteria as well as intracellular
pathogens.53–56
Although it is impossible to recreate natural selection
in vitro, functional experiments examining cellular
response to pathogens have helped to characterize path-
ogen-specific host response networks. We find that four
genes with evidence for selection and cis-eQTL effects526 The American Journal of Human Genetics 92, 517–529, April 4, 2013(IRF1, PLEK [MIM 173570], DEXI,
CD86 [MIM 601020]) are part of regu-
latory networks that control the tran-
scriptional response to a viral or bacte-
rial construct in mouse primary
dendritic cells (DCs).25 In addition,
several of the selected genes
(TMEM116, UHRF1BP1, IRF1, DEXI,
RNASET2 [MIM 612944], CD86,
PLEK) are significantly differentially
expressed in a recent study of 65
individuals whose primary dendritic
cells (DCs) were challenged with
Mycobacterium tuberculosis (MTB)
infection.26 Finally, three of theselected genes (FUT2, SH2B3, IRF1) contain variants that
are highly correlated with current estimates of local path-
ogen diversity,8 lending additional support for a role of
pathogens in shaping levels and patterns of genetic varia-
tion at loci influencing inflammatory-disease susceptibility.
It is perhaps not surprising that many of the selected
regions harbor genes and molecular pathways that are
directly involved in immune response to pathogens. Infec-
tious diseases have been one of the major causes of death
throughout human history. Since the agricultural revolu-
tion, human populations expanded rapidly and developed
resistance to a number of microbial and parasitic patho-
gens, and as a consequence, natural selection probably
played a major role in shaping human genetic variation.
In the context of inflammatory diseases, it is plausible
that signatures of recent positive selection observed in
the susceptibility alleles are due to an overactive immune
system, driven at least in part by immune response to
pathogen exposure in the past. This is consistent with
the ‘‘hygiene hypothesis,’’ which postulates that lack of
exposure to infectious agents in the modern environment
increases susceptibility to inflammatory disease as a result
of imbalance of the immune system.22
Given the timing of the putative selective event
exerting an influence on the core selected PPI network
(1,200–2,600 years ago) (Figure 3; Table S4) and the avail-
ability of recorded history in European populations during
this time, we can speculate as to the nature of the selective
pressure. The confidence interval on these estimates is
large (400–700 years), and thus we must be cautious in in-
terpreting the estimated dates for the selective events.
Although many pathogens were doubtlessly influencing
human populations during the time period of selection
that we estimate, few had as dramatic effects as the recur-
rent epidemics of bubonic plague in European popula-
tions. Although intriguing, the convergence of our results
with this historical record should be seen as speculative
because our understanding of the role of pathogens during
this period is incomplete. Nonetheless, this scenario is
biologically plausible because the core selected network
that influences Th17 and other cells of the adaptive
immune system has been implicated in resistance to
Yersinia pestis (the organism causing plague) in a mouse
model.57
Overall, our integrated analyses contribute to under-
standing the organization of the large collection of suscep-
tibility genes for inflammatory diseases, many of which
are shared by several diseases:32,38,58,59 it provides a frame-
work with which to generate hypotheses and design new
experiments to better understand how genetic variation
contributing to variation in immune function via alter-
ations in gene expression and other mechanisms ulti-
mately leads to immune dysfunction in some individuals
as they encounter environmental risk factors in our
modern environment. For example, our core network of
interconnected, selected susceptibility genes highlights
several genes not known to be involved in pathogenic
Th17 cell differentiation, function, or regulation. Our
data suggest that these genes should be investigated in
this context, and our eQTL analyses suggest that alter-
ations in gene expression may be one mechanism by
which several of the selected variants might influence
immune function. These results may also be helpful in
refining causal variants within each locus for future ex-
perimental validation and characterization. Finally, our
analyses of natural selection provide a framework for the
remarkable extent of shared genetic architecture among
inflammatory diseases: it may be the by-product of
beneficial variation in keymolecular pathways influencing
the activation of the immune system in response to
pathogens that now influences aberrant response to self-
antigens. The core selected network (Figure 3) contains
genes that influence susceptibility to multiple different
diseases and may be critical to setting the likelihood
of responses to self-antigens, whereas disease-specific
susceptibility loci may play a greater role in the syndromic
manifestations of an immune reaction against self.Supplemental Data
Supplemental Data include six figures and four tables and can be
found with this article online at http://www.cell.com/AJHG/.The AmAcknowledgments
We thank Christophe Benoist for his leadership on RC2
GM093080. We thank Michelle Lee for sample collection and
Katherine Rothamel for data generation. The authors are grateful
to Vijay Kuchroo, Eli Stahl, and Chris Cotsapas for comments on
a previous version of the manuscript. This work is supported by
the National Institutes of Health (NIH) (RC2 GM093080, R01
NS067305, and F32 AG043267). P.L.D. is a HarryWeaver Neurosci-
ence Scholar of the NationalMultiple Sclerosis Society (JF2138A1).
Received: October 9, 2012
Revised: November 13, 2012
Accepted: March 1, 2013
Published: March 21, 2013Web Resources
The URLs for data presented herein are as follows:
DAPPLE, http://www.broadinstitute.org/mpg/dapple/dapple.php
GWAS Catalog, http://www.genome.gov/gwastudies/
Haplotter, http://haplotter.uchicago.edu/
iHS software, http://hgdp.uchicago.edu/Software/
InnateDB, http://www.innatedb.ca/
International HapMap Project, http://hapmap.ncbi.nlm.nih.gov/
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.org/
RefSeq, http://www.ncbi.nlm.nih.gov/RefSeqAccession Numbers
The data are available on the Gene Expression Omnibus website
(GSE16214).References
1. Barreiro, L.B., and Quintana-Murci, L. (2010). From evolu-
tionary genetics to human immunology: how selection shapes
host defence genes. Nat. Rev. Genet. 11, 17–30.
2. Voight, B.F., Kudaravalli, S., Wen, X., and Pritchard, J.K.
(2006). A map of recent positive selection in the human
genome. PLoS Biol. 4, e72.
3. Sabeti, P.C., Varilly, P., Fry, B., Lohmueller, J., Hostetter, E., Cot-
sapas, C., Xie, X., Byrne, E.H., McCarroll, S.A., Gaudet, R.,
et al.; International HapMap Consortium. (2007). Genome-
wide detection and characterization of positive selection in
human populations. Nature 449, 913–918.
4. Nielsen, R., Williamson, S., Kim, Y., Hubisz, M.J., Clark, A.G.,
and Bustamante, C. (2005). Genomic scans for selective
sweeps using SNP data. Genome Res. 15, 1566–1575.
5. Barreiro, L.B., Laval, G., Quach, H., Patin, E., and Quintana-
Murci, L. (2008). Natural selection has driven population
differentiation in modern humans. Nat. Genet. 40, 340–345.
6. Pickrell, J.K., Coop, G., Novembre, J., Kudaravalli, S., Li, J.Z.,
Absher, D., Srinivasan, B.S., Barsh, G.S., Myers, R.M., Feldman,
M.W., and Pritchard, J.K. (2009). Signals of recent positive
selection in a worldwide sample of human populations.
Genome Res. 19, 826–837.
7. Fumagalli, M., Pozzoli, U., Cagliani, R., Comi, G.P., Bresolin,
N., Clerici, M., and Sironi, M. (2010). Genome-wideerican Journal of Human Genetics 92, 517–529, April 4, 2013 527
identification of susceptibility alleles for viral infections
through a population genetics approach. PLoS Genet. 6,
e1000849.
8. Fumagalli, M., Sironi, M., Pozzoli, U., Ferrer-Admetlla, A., Pat-
tini, L., and Nielsen, R. (2011). Signatures of environmental
genetic adaptation pinpoint pathogens as the main selective
pressure through human evolution. PLoS Genet. 7, e1002355.
9. Corona, E., Dudley, J.T., and Butte, A.J. (2010). Extreme evolu-
tionary disparities seen in positive selection across seven
complex diseases. PLoS ONE 5, e12236.
10. Casto, A.M., and Feldman, M.W. (2011). Genome-wide asso-
ciation study SNPs in the human genome diversity project
populations: does selection affect unlinked SNPs with shared
trait associations? PLoS Genet. 7, e1001266.
11. Sabeti, P.C., Schaffner, S.F., Fry, B., Lohmueller, J., Varilly, P.,
Shamovsky, O., Palma, A., Mikkelsen, T.S., Altshuler, D., and
Lander, E.S. (2006). Positive natural selection in the human
lineage. Science 312, 1614–1620.
12. Nielsen, R., Hellmann, I., Hubisz, M., Bustamante, C., and
Clark, A.G. (2007). Recent and ongoing selection in the
human genome. Nat. Rev. Genet. 8, 857–868.
13. Walsh, E.C., Sabeti, P., Hutcheson, H.B., Fry, B., Schaffner, S.F.,
de Bakker, P.I., Varilly, P., Palma, A.A., Roy, J., Cooper, R., et al.
(2006). Searching for signals of evolutionary selection in 168
genes related to immune function. Hum. Genet. 119, 92–102.
14. Akey, J.M., Zhang, G., Zhang, K., Jin, L., and Shriver, M.D.
(2002). Interrogating a high-density SNP map for signatures
of natural selection. Genome Res. 12, 1805–1814.
15. Akey, J.M. (2009). Constructing genomic maps of positive
selection in humans: where do we go from here? Genome
Res. 19, 711–722.
16. Franke, A., McGovern, D.P., Barrett, J.C., Wang, K., Radford-
Smith, G.L., Ahmad, T., Lees, C.W., Balschun, T., Lee, J., Rob-
erts, R., et al. (2010). Genome-wide meta-analysis increases to
71 the number of confirmed Crohn’s disease susceptibility
loci. Nat. Genet. 42, 1118–1125.
17. Carlsson, B., Kindberg, E., Buesa, J., Rydell, G.E., Lido´n, M.F.,
Montava, R., Abu Mallouh, R., Grahn, A., Rodrı´guez-Dı´az, J.,
Bellido, J., et al. (2009). The G428A nonsense mutation in
FUT2 provides strong but not absolute protection against
symptomatic GII.4 Norovirus infection. PLoS ONE 4, e5593.
18. Zhernakova, A., Elbers, C.C., Ferwerda, B., Romanos, J.,
Trynka, G., Dubois, P.C., de Kovel, C.G., Franke, L., Oosting,
M., Barisani, D., et al.; Finnish Celiac Disease Study Group.
(2010). Evolutionary and functional analysis of celiac risk
loci reveals SH2B3 as a protective factor against bacterial infec-
tion. Am. J. Hum. Genet. 86, 970–977.
19. Hughes, A.L., and Nei, M. (1988). Pattern of nucleotide substi-
tution at major histocompatibility complex class I loci reveals
overdominant selection. Nature 335, 167–170.
20. Prugnolle, F., Manica, A., Charpentier, M., Gue´gan, J.F., Guer-
nier, V., and Balloux, F. (2005). Pathogen-driven selection and
worldwide HLA class I diversity. Curr. Biol. 15, 1022–1027.
21. Qutob, N., Balloux, F., Raj, T., Liu, H., Marion de Proce´, S.,
Trowsdale, J., and Manica, A. (2012). Signatures of historical
demography and pathogen richness on MHC class I genes.
Immunogenetics 64, 165–175.
22. Strachan, D.P. (1989). Hay fever, hygiene, and household size.
BMJ 299, 1259–1260.
23. Strachan, D.P. (2000). Family size, infection and atopy: the
first decade of the ‘‘hygiene hypothesis’’. Thorax 55(Suppl 1 ),
S2–S10.528 The American Journal of Human Genetics 92, 517–529, April 4, 224. Stranger, B.E., Stahl, E.A., and Raj, T. (2011). Progress and
promise of genome-wide association studies for human
complex trait genetics. Genetics 187, 367–383.
25. Amit, I., Garber, M., Chevrier, N., Leite, A.P., Donner, Y., Eisen-
haure, T., Guttman, M., Grenier, J.K., Li, W., Zuk, O., et al.
(2009). Unbiased reconstruction of a mammalian transcrip-
tional network mediating pathogen responses. Science 326,
257–263.
26. Barreiro, L.B., Tailleux, L., Pai, A.A., Gicquel, B., Marioni, J.C.,
and Gilad, Y. (2012). Deciphering the genetic architecture of
variation in the immune response to Mycobacterium tubercu-
losis infection. Proc. Natl. Acad. Sci. USA 109, 1204–1209.
27. Cortes, A., and Brown,M.A. (2011). Promise and pitfalls of the
Immunochip. Arthritis Res. Ther. 13, 101.
28. Weir, B.S., and Cockerham, C.C. (1984). Estimating F-statistics
for the analysis of population structure. Evolution 38, 1358–
1370.
29. Mueller, J.C., and Andreoli, C. (2004). Plotting haplotype-
specific linkage disequilibrium patterns by extended haplo-
type homozygosity. Bioinformatics 20, 786–787.
30. Zeller, T., Wild, P., Szymczak, S., Rotival, M., Schillert, A., Cas-
tagne, R., Maouche, S., Germain, M., Lackner, K., Rossmann,
H., et al. (2010). Genetics and beyond—the transcriptome of
human monocytes and disease susceptibility. PLoS ONE 5,
e10693.
31. Lage, K., Hansen, N.T., Karlberg, E.O., Eklund, A.C., Roque,
F.S., Donahoe, P.K., Szallasi, Z., Jensen, T.S., and Brunak, S.
(2008). A large-scale analysis of tissue-specific pathology and
gene expression of human disease genes and complexes.
Proc. Natl. Acad. Sci. USA 105, 20870–20875.
32. Rossin, E.J., Lage, K., Raychaudhuri, S., Xavier, R.J., Tatar, D.,
Benita, Y., Cotsapas, C., and Daly, M.J.; International Inflam-
matory Bowel Disease Genetics Constortium. (2011). Proteins
encoded in genomic regions associated with immune-
mediated disease physically interact and suggest underlying
biology. PLoS Genet. 7, e1001273.
33. De Jager, P.L., Jia, X., Wang, J., de Bakker, P.I., Ottoboni, L.,
Aggarwal, N.T., Piccio, L., Raychaudhuri, S., Tran, D., Aubin,
C., et al.; International MS Genetics Consortium. (2009).
Meta-analysis of genome scans and replication identify CD6,
IRF8 and TNFRSF1A as new multiple sclerosis susceptibility
loci. Nat. Genet. 41, 776–782.
34. Stranger, B.E., Nica, A.C., Forrest, M.S., Dimas, A., Bird, C.P.,
Beazley, C., Ingle, C.E., Dunning, M., Flicek, P., Koller, D.,
et al. (2007). Population genomics of human gene expression.
Nat. Genet. 39, 1217–1224.
35. Pritchard, J.K., Pickrell, J.K., and Coop, G. (2010). The genetics
of human adaptation: hard sweeps, soft sweeps, and polygenic
adaptation. Curr. Biol. 20, R208–R215.
36. Myles, S., Davison, D., Barrett, J., Stoneking, M., and Timpson,
N. (2008). Worldwide population differentiation at disease-
associated SNPs. BMC Med. Genomics 1, 22.
37. Lynn, D.J., Winsor, G.L., Chan, C., Richard, N., Laird, M.R.,
Barsky, A., Gardy, J.L., Roche, F.M., Chan, T.H., Shah, N.,
et al. (2008). InnateDB: facilitating systems-level analyses of
the mammalian innate immune response. Mol. Syst. Biol.
4, 218.
38. Cotsapas, C., Voight, B.F., Rossin, E., Lage, K., Neale, B.M.,
Wallace, C., Abecasis, G.R., Barrett, J.C., Behrens, T., Cho, J.,
et al.; FOCiS Network of Consortia. (2011). Pervasive sharing
of genetic effects in autoimmune disease. PLoS Genet. 7,
e1002254.013
39. Patsopoulos, N.A., Esposito, F., Reischl, J., Lehr, S., Bauer, D.,
Heubach, J., Sandbrink, R., Pohl, C., Edan, G., Kappos, L.,
et al.; Bayer Pharma MS Genetics Working Group; Steering
Committees of Studies Evaluating IFNb-1b and a CCR1-
Antagonist; ANZgene Consortium; GeneMSA; International
Multiple Sclerosis Genetics Consortium. (2011). Genome-
widemeta-analysis identifies novel multiple sclerosis suscepti-
bility loci. Ann. Neurol. 70, 897–912.
40. Lage, K., Karlberg, E.O., Størling, Z.M., Olason, P.I., Pedersen,
A.G., Rigina, O., Hinsby, A.M., Tu¨mer, Z., Pociot, F., Tom-
merup, N., et al. (2007). A human phenome-interactome
network of protein complexes implicated in genetic disorders.
Nat. Biotechnol. 25, 309–316.
41. Raj, T., Shulman, J.M., Keenan, B.T., Chibnik, L.B., Evans,
D.A., Bennett, D.A., Stranger, B.E., and De Jager, P.L. (2012).
Alzheimer disease susceptibility loci: evidence for a protein
network under natural selection. Am. J. Hum. Genet. 90,
720–726.
42. Stranger, B.E., Montgomery, S.B., Dimas, A.S., Parts, L., Stegle,
O., Ingle, C.E., Sekowska, M., Smith, G.D., Evans, D., Gutier-
rez-Arcelus, M., et al. (2012). Patterns of cis regulatory varia-
tion in diverse human populations. PLoS Genet. 8, e1002639.
43. Murphy, A., Chu, J.H., Xu, M., Carey, V.J., Lazarus, R., Liu, A.,
Szefler, S.J., Strunk, R., Demuth, K., Castro, M., et al. (2010).
Mapping of numerous disease-associated expression polymor-
phisms in primary peripheral blood CD4þ lymphocytes.
Hum. Mol. Genet. 19, 4745–4757.
44. Gateva, V., Sandling, J.K., Hom, G., Taylor, K.E., Chung, S.A.,
Sun, X., Ortmann, W., Kosoy, R., Ferreira, R.C., Nordmark,
G., et al. (2009). A large-scale replication study identifies
TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for
systemic lupus erythematosus. Nat. Genet. 41, 1228–1233.
45. Pruim, R.J., Welch, R.P., Sanna, S., Teslovich, T.M., Chines,
P.S., Gliedt, T.P., Boehnke, M., Abecasis, G.R., and Willer, C.J.
(2010). LocusZoom: regional visualization of genome-wide
association scan results. Bioinformatics 26, 2336–2337.
46. Nica, A.C., Montgomery, S.B., Dimas, A.S., Stranger, B.E., Beaz-
ley, C., Barroso, I., and Dermitzakis, E.T. (2010). Candidate
causal regulatory effects by integration of expression QTLs
with complex trait genetic associations. PLoS Genet. 6,
e1000895.
47. Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V.K. (2009).
IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485–517.
48. Cooke, A. (2006). Th17 cells in inflammatory conditions. Rev.
Diabet. Stud. 3, 72–75.The Am49. Abraham, C., and Cho, J.H. (2009). IL-23 and autoimmunity:
new insights into the pathogenesis of inflammatory bowel
disease. Annu. Rev. Med. 60, 97–110.
50. Stockinger, B., and Veldhoen, M. (2007). Differentiation and
function of Th17 T cells. Curr. Opin. Immunol. 19, 281–286.
51. Peters, A., Lee, Y., and Kuchroo, V.K. (2011). Themany faces of
Th17 cells. Curr. Opin. Immunol. 23, 702–706.
52. Maddur, M.S., Miossec, P., Kaveri, S.V., and Bayry, J. (2012).
Th17 cells: biology, pathogenesis of autoimmune and inflam-
matory diseases, and therapeutic strategies. Am. J. Pathol. 181,
8–18.
53. Happel, K.I., Dubin, P.J., Zheng, M., Ghilardi, N., Lockhart, C.,
Quinton, L.J., Odden, A.R., Shellito, J.E., Bagby, G.J., Nelson,
S., and Kolls, J.K. (2005). Divergent roles of IL-23 and IL-12
in host defense against Klebsiella pneumoniae. J. Exp. Med.
202, 761–769.
54. Aujla, S.J., Chan, Y.R., Zheng, M., Fei, M., Askew, D.J., Pociask,
D.A., Reinhart, T.A., McAllister, F., Edeal, J., Gaus, K., et al.
(2008). IL-22 mediates mucosal host defense against Gram-
negative bacterial pneumonia. Nat. Med. 14, 275–281.
55. Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M.,
Gong, Q., Abbas, A.R., Modrusan, Z., Ghilardi, N., de Sauvage,
F.J., and Ouyang, W. (2008). Interleukin-22 mediates early
host defense against attaching and effacing bacterial patho-
gens. Nat. Med. 14, 282–289.
56. Khader, S.A., and Gopal, R. (2010). IL-17 in protective immu-
nity to intracellular pathogens. Virulence 1, 423–427.
57. Derbise, A., Cerda Marin, A., Ave, P., Blisnick, T., Huerre, M.,
Carniel, E., and Demeure, C.E. (2012). An encapsulated
Yersinia pseudotuberculosis is a highly efficient vaccine against
pneumonic plague. PLoS Negl. Trop. Dis. 6, e1528.
58. Zhernakova, A., Stahl, E.A., Trynka, G., Raychaudhuri, S., Fes-
ten, E.A., Franke, L., Westra, H.J., Fehrmann, R.S., Kurreeman,
F.A., Thomson, B., et al. (2011). Meta-analysis of genome-wide
association studies in celiac disease and rheumatoid arthritis
identifies fourteen non-HLA shared loci. PLoS Genet. 7,
e1002004.
59. Zhernakova, A., van Diemen, C.C., and Wijmenga, C. (2009).
Detecting shared pathogenesis from the shared genetics of
immune-related diseases. Nat. Rev. Genet. 10, 43–55.
60. Dixon, A.L., Liang, L., Moffatt, M.F., Chen, W., Heath, S.,
Wong, K.C., Taylor, J., Burnett, E., Gut, I., Farrall, M., et al.
(2007). A genome-wide association study of global gene
expression. Nat. Genet. 39, 1202–1207.erican Journal of Human Genetics 92, 517–529, April 4, 2013 529
